BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25224558)

  • 1. Association of variants in genes related to the immune response and obesity with BPH in CLUE II.
    Lopez DS; Peskoe SB; Tsilidis KK; Hoffman-Bolton J; Helzlsouer KJ; Isaacs WB; Smith MW; Platz EA
    Prostate Cancer Prostatic Dis; 2014 Dec; 17(4):353-8. PubMed ID: 25224558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of common polymorphisms in IL10, and in other genes related to inflammatory response and obesity with colorectal cancer.
    Tsilidis KK; Helzlsouer KJ; Smith MW; Grinberg V; Hoffman-Bolton J; Clipp SL; Visvanathan K; Platz EA
    Cancer Causes Control; 2009 Nov; 20(9):1739-51. PubMed ID: 19760027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in genes related to inflammation and obesity and colorectal adenoma risk.
    Huang BZ; Tsilidis KK; Smith MW; Hoffman-Bolton J; Visvanathan K; Platz EA; Joshu CE
    Mol Carcinog; 2018 Oct; 57(10):1278-1288. PubMed ID: 29802748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of IL10 and other immune response- and obesity-related genes with prostate cancer in CLUE II.
    Wang MH; Helzlsouer KJ; Smith MW; Hoffman-Bolton JA; Clipp SL; Grinberg V; De Marzo AM; Isaacs WB; Drake CG; Shugart YY; Platz EA
    Prostate; 2009 Jun; 69(8):874-85. PubMed ID: 19267370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the Prostate Cancer Prevention Trial.
    Winchester DA; Till C; Goodman PJ; Tangen CM; Santella RM; Johnson-Pais TL; Leach RJ; Xu J; Zheng SL; Thompson IM; Lucia MS; Lippman SM; Parnes HL; Isaacs WB; De Marzo AM; Drake CG; Platz EA
    Prostate; 2017 Jun; 77(8):908-919. PubMed ID: 28317149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A genetic variant near GATA3 implicated in inherited susceptibility and etiology of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS).
    Na R; Helfand BT; Chen H; Conran CA; Crawford SE; Hayward SW; Tammela TLJ; Hoffman-Bolton J; Zheng SL; Walsh PC; Schleutker J; Platz EA; Isaacs WB; Xu J
    Prostate; 2017 Aug; 77(11):1213-1220. PubMed ID: 28656603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The associations among eNOS G894T gene polymorphism, erectile dysfunction, and benign prostate hyperplasia-related lower urinary tract symptoms.
    Lee YC; Wu WJ; Liu CC; Wang CJ; Li WM; Huang CH; Yeh HC; Ke HL; Huang SP
    J Sex Med; 2009 Nov; 6(11):3158-65. PubMed ID: 19515207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutathione S-transferase gene variants and risk of benign prostate hyperplasia in a North Indian population.
    Konwar R; Manchanda PK; Chaudhary P; Nayak VL; Singh V; Bid HK
    Asian Pac J Cancer Prev; 2010; 11(2):365-70. PubMed ID: 20843117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical activity and benign prostatic hyperplasia.
    Platz EA; Kawachi I; Rimm EB; Colditz GA; Stampfer MJ; Willett WC; Giovannucci E
    Arch Intern Med; 1998 Nov; 158(21):2349-56. PubMed ID: 9827786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutathione S-transferase (GST) gene variants and risk of benign prostatic hyperplasia: a report in a North Indian population.
    Konwar R; Manchanda PK; Chaudhary P; Nayak VL; Singh V; Bid HK
    Asian Pac J Cancer Prev; 2010; 11(4):1067-72. PubMed ID: 21133626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variants in 5p13.2 and 7q21.1 are associated with treatment for benign prostatic hyperplasia with the α-adrenergic receptor antagonist.
    Qian X; Xu D; Liu H; Lin X; Yu Y; Kang J; Sheng X; Xu J; Zheng S; Xu D; Qi J
    Aging Male; 2017 Dec; 20(4):250-256. PubMed ID: 28787260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rural vs. urban disparities in association with lower urinary tract symptoms and benign prostatic hyperplasia in ageing men, NHANES 2001-2008.
    Egan KB; Suh M; Rosen RC; Burnett AL; Ni X; Wong DG; McVary KT
    Int J Clin Pract; 2015 Nov; 69(11):1316-25. PubMed ID: 26215544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of benign prostate hyperplasia with polymorphisms in VDR, CYP17, and SRD5A2 genes among Lebanese men.
    El Ezzi AA; Zaidan WR; El-Saidi MA; Al-Ahmadieh N; Mortenson JB; Kuddus RH
    Asian Pac J Cancer Prev; 2014; 15(3):1255-62. PubMed ID: 24606449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of BPH, lower urinary tract symptoms, and PSA levels on erectile function of Brazilian men who undergo prostate cancer screening.
    Antunes AA; Srougi M; Dall'oglio MF; Vicentini F; Paranhos M; Freire GC
    J Sex Med; 2008 Jul; 5(7):1702-7. PubMed ID: 18194186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH) combined responders to tadalafil after 12 weeks of treatment.
    Roehrborn CG; Egan KB; Miner MM; Ni X; Wong DG; Rosen RC
    BJU Int; 2016 Jul; 118(1):153-60. PubMed ID: 26765325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial.
    Winchester DA; Till C; Goodman PJ; Tangen CM; Santella RM; Johnson-Pais TL; Leach RJ; Xu J; Zheng SL; Thompson IM; Lucia MS; Lippmann SM; Parnes HL; Dluzniewski PJ; Isaacs WB; De Marzo AM; Drake CG; Platz EA
    Prostate; 2015 Sep; 75(13):1403-18. PubMed ID: 26047319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autonomic nervous system overactivity in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia.
    McVary KT; Rademaker A; Lloyd GL; Gann P
    J Urol; 2005 Oct; 174(4 Pt 1):1327-433. PubMed ID: 16145413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between polymorphisms in the steroid 5-alpha reductase type II (SRD5A2) gene and benign prostatic hyperplasia and prostate cancer.
    Salam MT; Ursin G; Skinner EC; Dessissa T; Reichardt JK
    Urol Oncol; 2005; 23(4):246-53. PubMed ID: 16018939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of CCL2, CCR2 and CCL5 genetic polymorphisms with the development and progression of benign prostatic hyperplasia.
    Pang Y; Li H; Gong Y; Jing S; Peng C; Liu W; Zhao Y; Wang H; Kaushik D; Rodriguez R; Wang Z
    Oncol Rep; 2019 Apr; 41(4):2491-2501. PubMed ID: 30816510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide synthase 2 gene polymorphisms are associated with prostatic volume in Korean men with benign prostatic hyperplasia.
    Yoo KH; Kim SK; Chung JH; Chang SG
    Asian J Androl; 2010 Sep; 12(5):690-6. PubMed ID: 20562898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.